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ABSTRACT
Helicase-like SWI/SNF proteins are present in
organisms belonging to distant kingdoms from
bacteria to humans, indicating that they perform a
very basic and ubiquitous form of nucleic acid
management; current studies associate the activity
of SWI/SNF proteins with remodeling of DNA and
DNA–protein complexes. The bacterial SWI/SNF
homolog RapA—an integral part of the Escherichia
coli RNA polymerase complex—has been impli-
cated in remodeling post-termination DNA–RNA
polymerase–RNA ternary complexes (PTC), however
its explicit nucleic acid substrates and mechanism
remain elusive. Our work presents evidence indicat-
ing that RNA is a key substrate of RapA. Specifically,
the formation of stable RapA–RNA intermediates in
transcription and other, independent lines of evi-
dence presented herein indicate that RapA binds
and remodels RNA during transcription. Our results
are consistent with RapA promoting RNA release
from DNA–RNA polymerase–RNA ternary com-
plexes; this process may be accompanied by
the destabilization of non-canonical DNA–RNA
complexes (putative DNA–RNA triplexes). Taken
together, our data indicate a novel RNA remodeling
activity for RapA, a representative of the SWI/SNF
protein superfamily.
INTRODUCTION
The SWI/SNF superfamily of proteins contains a large
number of representatives, present in many living species
from bacteria to humans, which share six characteristic
helicase-like motifs (1–3). However, the explicit role of
these helicase-like protein subdomains remains undeter-
mined, and none of the proteins of this superfamily
described to date has shown helicase activity in
conventional in vitro helicase assays utilizing duplex
nucleic acid substrates. Mutations in SWI/SNF genes
have been associated with pediatric cancers of brain and
soft tissue (4,5) and leukemia (6); multiple, independent
studies indicate that SWI/SNF proteins act as tumor
suppressors (7–10). In vitro, puriﬁed SWI/SNF complexes
produce ATP-dependent alterations of the chromatin
structure, and these observations eventually led to the
idea that SWI/SNF complexes act primarily as chromatin
remodeling machines (11–14). In mammals, Drosophila
and yeast, the multiple individual SWI/SNF polypeptides
are present as integral components of large multi-subunit
nuclear complexes. The speciﬁc roles of individual SWI/
SNF polypeptides in eukaryotic SWI/SNF and other
nuclear complexes are debated. It has been suggested that
the ATP-propelled sliding of SWI/SNF proteins along
DNA might enhance nucleosome translocation during
transcription and other cellular events that involve DNA
(15–18). Existing studies associate the activity of SWI/
SNF proteins almost exclusively with remodeling of DNA
and histone–DNA complexes, and their primary role
in vivo is proposed to be global regulation of transcription
and gene expression.
In contrast, Escherichia coli contains only a single
110-kDa SWI/SNF polypeptide (19,20), which shares
homology with its eukaryotic counterparts throughout
six characteristic helicase-like subdomains (1–3), suggest-
ing that they share similar basic functions. This homology
also makes the E. coli SWI/SNF protein RapA (19,21)
a particularly attractive target for analysis of the explicit
role(s) of SWI/SNF polypeptides. RapA—also referred
to as HepA (20)—was identiﬁed as a subunit of the E. coli
RNA polymerase complex (19,22,23). This relatively
abundant protein, the copy number of which is roughly
comparable to that of the RNA polymerase sigma
70
subunit, binds preferentially to the core RNA polymerase
(with the Kd of the complex being in the nanomolar range,
indicating a high degree of speciﬁcity of the interaction)
at the interface of the alpha and beta-prime RNA
polymerase subunits (22). Rigorous study of rapA deletion
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alterations in their rate of growth, mutation rates or UV
sensitivity in comparison with rapA plus strains under a
variety of experimental conditions (22), suggesting
that the role of RapA diﬀers from those proposed for
eukaryotic SWI/SNF polypeptides. However, rapA dele-
tion produces a unique phenotype, rendering bacteria
incapable of eﬃcient growth at relatively high salt
concentrations in LB agar (23). Analysis of the role of
RapA in transcription has indicated its capability for
conditional stimulation of the polymerase’s transcrip-
tional activity (in a salt concentration-speciﬁc fashion,
consistent with the in vivo eﬀect of the rapA deletion
mutation) likely via promoting the dissociation of one or
more components of the DNA–RNA polymerase–RNA
ternary complex (23). However, it remains unclear which
component(s) of non-productive post-termination ternary
complexes are speciﬁcally targeted by RapA; our previous
hypotheses—based on studies with eukaryotic SWI/SNF
proteins—solely focused on DNA as a substrate of RapA.
The question of the explicit nucleic acid- and/or protein
substrate speciﬁcity of RapA is important, because the
function of SWI/SNF motifs V and VI have not been fully
explained. Although they are present in all SWI/SNF
proteins in addition to helicase-like motifs I–IV, studies of
distantly related DEAD/H DNA helicases have suggested
that motifs I–IV may be suﬃcient for translocation
along DNA. X-ray structures of the catalytic domain of
the RapA homolog from Sulfolobus solfataricus
(SsoRad54) complexed to DNA have further conﬁrmed
DNA binding by a bacterial SWI/SNF protein and
indicate that SWI/SNF motifs I–III and IV–VI form two
semi-autonomous modules, both of which are bound to
DNA in the reported structure (24).
Our most recent work has focused on the determination
of preferred nucleic acid and/or protein substrates of
RapA. Excess RapA was previously shown to produce
complex eﬀects on in vitro transcription, which included
inhibitory eﬀects at ‘early’ timepoints and a signiﬁcant
increase in the number of completed transcriptional
rounds in prolonged in vitro transcription reactions,
which was attributed to RapAs remodeling of DNA–
RNA polymerase–RNA ternary complexes (23). In this
study—given that the interaction of RapA with the
polymerase is well established—using primarily puriﬁed
native RapA (21) at a ‘physiological’ (1:1) molar ratio
with the polymerase, we have conducted experiments in
order to clarify the general mechanistic aspects of this
remodeling. Our work presents multiple, independent lines
of evidence indicating that RNA is a key substrate of
RapA. Our biochemical data, supported by a homology
model of the RapA NTPase domain–DNA complex,
suggest that this RNA-remodeling activity of RapA may
be in addition to its DNA-binding activity. Our results
are consistent with a model in which RapA promotes
RNA release from DNA–RNA polymerase–RNA ternary
complexes. Taken together, our data indicate a novel
RNA remodeling activity for RapA, a representative of
the SWI/SNF protein superfamily. This ﬁnding could
potentially deepen our understanding of the functions
of all SWI/SNF proteins, and may point to yet-
unidentiﬁed activities of eukaryotic SWI/SNF proteins.
MATERIALS AND METHODS
Enzymes
Native RapA was isolated as described (19,21). Core RNA
polymerase, RNA polymerase holoenzyme, NusA, S1 and
Hfq were puriﬁed as described (25). Recombinant RapA
was obtained by ampliﬁcation of the rapA gene from
MG1655 chromosomal DNA using MS152 (50-CGT
TAACGGATCCGACCCGGGCCTTTTACACTTGGT
CAACGCTGGATCAG) and MS153 (50-ATTGTCCCG
GGCTGCAGCCGACCGCTCGGCTTGTTGACCACC
ATAATATG) DNA primers, subcloning the resulting
PCR product into the XmaI site of the vector pQE32
(Qiagen), and overexpression and puriﬁcation of the
recombinant His-tagged protein as described (22). Over
90% of the rapA sequence (including 100% of the SWI/
SNF homology regions) was conﬁrmed by DNA sequen-
cing and found to be identical to that in the NCBI
database.
‘In vitro transcription experiments’ were carried out,
generally, as described (23), with the exceptions that,
when indicated, denaturation of the samples by boiling
following the addition of a 1/5 reaction volume of
5 Stop solution (50% glycerol, 100mM EDTA, pH
7.5, 0.1% bromphenol blue) was omitted, and the ﬁnal
RNA polymerase holoenzyme concentrations were
0.05–0.06mg/ml. The RNA polymerase–(native)RapA
ratio in all described experiments (unless indicated
otherwise in the ﬁgure legend) was 1:1. No detectable
diﬀerences (in in vitro transcription or other enzymatic
assays described in this study) were found between the 1:1
RNA polymerase RapA complexes obtained during the
course of previously described puriﬁcation procedures
(19,21,25) and the same complexes reconstituted from
puriﬁed RNA polymerase and RapA. All described
experiments utilized native RapA, with the exception of
the experiments described in Figure 5B, which were
carried out with recombinant (His-tagged) RapA.
Recombinant (His-tagged)RapA
K183A (23) was isolated
as described for wild-type recombinant protein (22).
Reaction buﬀers and the supercoiled plasmid DNA
templates are speciﬁed in the ﬁgure legends. Kinetics of
RNA synthesis were monitored, generally, as previously
described (23) for the reactions initiated by the addition of
rNTPs [see Ref. (23); Figure 5B therein], except that the
ﬁnal concentration of each rNTP was 0.2mM and
the RNA polymerase holoenzyme concentration was
0.05mg/ml.
Electrophoretic mobility shift assay(EMSA)
Protein–RNA binding assays. Proteins and the
32P-labeled
puriﬁed RNA probe (typically present at 500–1000c.p.m./
20ml binding reaction) were mixed in 50mM Tris–HCl,
pH 7.5, containing 5mM MgCl2, 0.5mg/ml BSA and
200mM NaCl. The binding reactions were incubated
for 5min at room temperature, and 5ml of loading buﬀer
(50% glycerol supplemented with 0.05% bromphenol
Nucleic Acids Research, 2007, Vol. 35, No. 21 7045blue) was added to each binding reaction. Aliquots of
2–8ml were then analyzed on 8% polyacrylamide gels
containing 0.5  TBE or 2  TBE, as described in
the legend to Figure 2. BioMax ML ﬁlm was exposed to
dried gels (typically 6–18h at  708C) with BioMax
MS screens.
DNA–RNA EMSA-binding experiments. Synthetic
RNA oligonucleotides were obtained from Dharmacon.
Nucleic acid probes were labeled at the 50-end using T4
polynucleotide kinase (USB) and [Gamma
32P] ATP
(MP Biomedicals), according to the USB protocol.
Following the end-labeling procedure, the RNA probes
were gel-puriﬁed on a denaturing 20% polyacrylamide gel
(National Diagnostics). The gel-puriﬁcation procedure for
RNA probes was as follows. After PAGE, X-ray ﬁlm was
exposed to a ‘wet’ gel that had been covered with plastic
wrap. Full-length RNA bands were visualized, marked
and cut from the gel. The polyacrylamide gel slice
containing the end-labeled RNA was then manually
homogenized in an RNase-free, 1.5ml Eppendorf tube-
size disposable homogenizer, typically using 200mlo f
2 TBE. Following the 2–3-min homogenization, the
slurry was immediately applied on a microcentrifuge
ﬁlter vial (Ultrafree-DA; Millipore), and the ﬂow-through
was aliquoted and stored at  708C. Synthetic DNA
oligonucleotides were either gel- or cartridge-puriﬁed.
DNA oligonucleotides obtained from two independent
vendors (Invitrogen and Sigma Genosys) were tested in
the DNA–RNA binding experiments, with similar results.
Key experiments (including the experiments described
in Figure 7B, C and Figure S5) were carried out with
synthetic DNA oligonucleotides obtained from
Invitrogen. DNA and RNA oligonucleotides were incu-
bated for 5min at room temperature in the buﬀers
speciﬁed in the Figure 7A legend, mixed with 1/5
volume of a loading buﬀer containing 50% glycerol
(Sigma Ultrapure) and 0.01% bromphenol blue and
analyzed by PAGE using 20 20cm, 1-mm thick 12%
polyacrylamide gels, which were cast and run using the
buﬀers speciﬁed in the legend to Figure 7A. Typically,
PAGE was performed at 20 milliamps/gel. Tris–Borate–
EDTA (TBE) buﬀer from two independent vendors
(KD Medical and MP Biomedicals)—obtained either as
a1 0   concentrate (KD Medical, MP Biomedicals) or a
premixed powder (MP Biomedicals)—was tested, with
similar results. The pH in diﬀerent batches of commer-
cially available 10  TBE was 7.8–8.3.
‘Immobilized DNA–RNA templates’ were construc-
ted by incubating agarose-bound polynucleotides
(Amersham-Pharmacia) with soluble DNA (either
[dA]20[dC]4[T]20 or [dA]20[dG]4[T]20; Invitrogen) or RNA
(50-CCUGUUUUUAAGGAGUGUCGCCAGAGGCC
GCGAUG[A]18-30; Dharmacon)
32P-labeled synthetic
oligonucleotides (0.05–0.1 A260U/ml) at room tempera-
ture, followed by extensive washing with 50mM Tris–HCl
(pH 7.5), 200mM NaCl, 5mM MgCl2. One hundred
microliters of binding reactions containing  20mlo f
agarose-bound DNA–RNA complexes were incubated
with gentle agitation at room temperature for 30min,
unless otherwise indicated in the ﬁgure legends, and the
nucleic acid content of the aqueous phase was determined.
The reaction ingredients were as described in the legend to
Figure 7B and Figure S4.
RESULTS
Previously, it was demonstrated that excess RapA can
promote transcriptional cycling via some undetermined
means of remodeling post-termination, DNA–RNA
polymerase–RNA ternary complexes (23). However,
it is unclear which component(s) of the ternary, post-
termination DNA–RNA polymerase–RNA complex
(PTC) are targeted by RapA. In principle, RapA may (i)
facilitate the release of nascent RNA from RNA
polymerase (Model 1, Figure 1A), (ii) promote the release
of RNA polymerase (with or without nascent RNA) from
DNA (Model 2, Figure 1B), and/or (iii) stimulate
transcriptional cycling by means of disrupting non-
productive DNA–RNA complexes, irrespective of either
the DNA-bound or free status of the polymerase (Model
3, Figure 1C). [Factors that may potentially hinder
transcriptional cycling are summarized in our recent
study (26).] (iv) Alternatively, RapA activity can be
described as a combination of Models 1 through 3
(particularly 1 and 3). In this study, we carried out
experiments to clarify the mechanistic aspects of RapA
catalysis in terms of its general compatibility with one or
more of the aforementioned models.
Model 1
Purified system. First, we tested the eﬀect of RapA on
the stability of RNA polymerase–RNA complexes in
Non-productive PTC
Model 2
Model 3
RapA
DNA
RNA
Polymerase
DNA
ATP ADP+Pi
ADP+Pi
ADP+Pi
Non-productive PTC
RNA
Polymerase
ATP
ATP
RNA
Non-productive PTC
RapA
DNA
RNA
Polymerase
Productive PTC
DNA
RNA
RNA
A
B
C
Productive PTC
Productive PTC
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RapA
RNA
DNA DNA
RNA
RNA
Figure 1. Three plausible mechanisms explaining the RapA-mediated
remodeling of non-productive post-termination complexes (23). See text
for a detailed description of each of the indicated models.
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using PAGE-based electrophoretic mobility shift assays
(EMSA) (Figure 2). The core RNA polymerase showed
higher RNA-binding aﬃnity than that of the RNA
polymerase holoenzyme (Figure 2; compare lanes 1–4
and lanes 10–12), and RapA showed no detectable RNA-
binding activity under these experimental conditions
(Figure 2; lanes 8 and 9). Formation of the RNA
polymerase–RapA complex was accompanied by a sig-
niﬁcant increase in the RNA-binding activity of the
complex compared to that of RNA polymerase alone;
the eﬀect was particularly dramatic for the RNA
polymerase holoenzyme (Figure 2; compare lanes 10–12
and lanes 13–15). We tested several diﬀerent RNAs of
varied length and structure and obtained similar results
using a short, 55-nt RNA consisting of two stem-loop
structures followed by an 18-nt (rA) tail (Figure 2) [RapA
ATPase activity was not aﬀected signiﬁcantly by the
presence of an excess of this secondary structure-
containing RNA (Supplementary Data; Figure S1), in
agreement with the previously reported results indicating a
lack of eﬀect of Poly[rA] on RapA-mediated ATP
hydrolysis (19)], rA20 (Supplementary Data; Figure S3)
and the bacteriophage lambda RNA I (data not shown).
We also compared side-by-side the aﬃnities of the RNA
polymerase holoenzyme–RapA complex to RNA and
DNA probes with matching (save U/T transitions)
nucleotide sequences (Supplementary Data; Figure S2).
These experiments further conﬁrmed that the complex is
capable of binding both DNA and RNA, with mild
(approximately 2-fold) preference of an mRNA-like RNA
probe over a similar DNA probe (Supplementary Data;
Figure S2).
In vitro transcription system. It is conceivable that if
RapA were to promote the release of RNA from
transcription complexes, RapA–RNA intermediates
might be detected during fractionation of the components
of in vitro transcription reactions by PAGE. The experi-
ments described below were carried out to detect such
hypothetical RapA–RNA and/or RNA polymerase–
RapA–RNA intermediates. Typically, in vitro transcrip-
tion reactions are denatured by boiling before their
RNA content can be analyzed by PAGE. Bypassing
the boiling step, we fractionated the content of entire
in vitro transcription reactions by PAGE on 6%
polyacrylamide–urea gels (Figure 3). This approach
revealed unique protein–RNA complexes present only in
the reactions containing RapA (Figure 3, complexes ‘B’;
the sensitivity to boiling distinguishes these complexes
from RNA transcripts). We tested whether these RapA-
speciﬁc complexes were promoter- or terminator-speciﬁc
and found that they were detected irrespective of the type
of DNA template used in the reactions (Figure 3A–D).
To determine the composition of these complexes, we
used two independent experimental approaches. In the
ﬁrst approach (an immunoassay), proteins and protein–
nucleic acid complexes were electroeluted from the gel
onto a membrane which was subsequently incubated with
either RNA polymerase-speciﬁc or RapA-speciﬁc poly-
clonal antibodies (in parallel reactions). In the second
approach, RapA-speciﬁc complexes (‘B’ complexes in
Figures 3 and 4), identiﬁed after exposure of X-ray ﬁlms
to ‘wet’ polyacrylamide gels, were excised from the gel;
the gel slices were homogenized in Laemmli sample buﬀer
and their content was analyzed on silver-stained SDS–
polyacrylamide gels. Both approaches produced consis-
tent results, indicating that the complexes in question
contain a sole polypeptide—RapA—and RNA (the results
of an immunoassay are shown in Figure 4). We also
analyzed the nature of the RapA-associated RNA
transcripts and determined that they are represented
predominantly by a major promoter-speciﬁc RNA
transcript, unique for each of the two sets of templates
used (data not shown).
Analysis of the kinetics of the RapA–RNA adduct
formation indicated nearly instantaneous RapA–RNA
interaction; there was a good correlation between the yield
of RapA–RNA adduct and that of promoter-speciﬁc
transcript in reactions with or without RapA (Figure 5A).
Excess BSA failed to signiﬁcantly reduce levels of RapA–
RNA adduct (Supplementary Data; Figure S4B) suggest-
ing that the transcript interacts speciﬁcally with RapA,
and stable RapA–transcript complexes were formed in
in vitro transcription reactions carried out in various
buﬀers, including 2  TBE containing 5mM magnesium
chloride (Supplementary Data; Figure S4A). [This buﬀer
-Free RNA
RNA-RNA polymerase
RNA-RNA polymerase-RapA 
L a n e 1 234567891 0 1 1 1 2 1 3 1 4 1 5
Figure 2. RapA promotes interaction of RNA polymerase with RNA.
EMSA gel illustrating the eﬀect of RapA on interaction of the core
RNA polymerase (lanes 2–7) or the RNA polymerase holoenzyme
(lanes 10–15) with end-labeled 55-nt RNA incorporating stem-loop
structures and an rA18 tail. EMSA-binding experiments were carried
out as described in Materials and Methods section. Other RNA probes
of varied length and structure (see text for details) produced similar
binding patterns, indicating a greatly increased RNA-binding aﬃnity of
the polymerase in the presence of RapA. Quantitation of the RNA
polymerase (holoenzyme)-bound RNA in the presence or absence of
RapA (lanes 15 and 12) indicated a >20-fold increase in RNA-binding
aﬃnity in the presence of RapA. Note that RapA abolishes
the formation of multimeric RNA polymerase–RNA complexes
formed by the core RNA polymerase (indicated with arrowheads).
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Figure 3. Formation of stable in vitro transcription reaction intermediates in the presence of RapA. In vitro transcription reactions with supercoiled
DNA templates were carried out, in general, as previously described (23), except that 1mol puriﬁed native RapA per mole of the RNA polymerase
holoenzyme (0.05–0.06mg/ml) was used throughout this study, unless indicated otherwise in the ﬁgure legends. Reaction products of 15min in vitro
transcription reactions (with or without 1-min boiling following the addition of a Stop solution) were fractionated on 6% PAA–urea gels. Buﬀer A:
50mM MOPS (pH 7.0), 5mM MgCl2; Buﬀer B: 50mM Tris–HCl (pH 7.9), 10mM MgCl2, 200mM NaCl, 1mM dithiothreitol. (A–D) Formation of
stable RapA-speciﬁc transcription reaction intermediates does not depend on the nature of a supercoiled DNA template. Templates 1 and 3, which
carry the T7A1 promoter and either lambda tr2 or t3te terminators are described in Ref. (27). Template 2, which carries the tac promoter and t1t2
terminator is described in Ref. (23). Template 4, which carries the lambda Pr promoter, but is otherwise similar to Template 2, was constructed by
substituting the tac promoter in Template 2 samples were initiated by the addition of rNTP mix containing either [Alpha-
32P] ATP (lanes 9–16) or
[Gamma-
32P] ATP plus T4 PNK (0.2U/ml) (lanes 1–8). The stock solutions of both radiolabeled nucleotides (see Materials and Methods section)
were diluted (typically, 120-fold and 9-fold, respectively) to obtain comparable incorporations of the label in the two sets of samples; the ﬁnal rNTP
concentrations remained the same ([ATP]=[UTP]=[GTP]=[CTP]=0.2mM). The formation of stable RapA-speciﬁc reaction intermediates with
all four diﬀerent DNA templates suggests that the eﬀect is not template-speciﬁc.
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7050 Nucleic Acids Research, 2007, Vol. 35, No. 21was tested in addition to ‘standard’ reaction buﬀers
(see Materials and Methods section) to validate the
comparison of data obtained from in vitro transcription
studies with those from PAGE-based binding assays
(see below)].
We next tested whether the disruption of RapA ATPase
activity by the Lys183Ala mutation (23) could have an
eﬀect on the formation of the RapA–RNA adduct. These
experiments have demonstrated, in general, reduced
ability of the RapA
Lys183Ala mutant to engage RNA
(Figure 5B; compare lanes 2 and 3, 8 and 9, 11 and 12); yet
mutant RapA was capable of forming protein–RNA
complexes (indicated with red arrowheads in Figure 5B)
under certain, presumably ‘optimal’ conditions (at 378C
and with relatively long transcripts produced from
Template 1; Figure 5B, lanes 5 and 6). It is tempting to
speculate that the increased level of RNA polymerase–
RapA
Lys183Ala–transcript complex compared to that in the
reaction with wild-type RapA, which correlated inversely
with the levels of ‘free’ promoter-speciﬁc transcripts in the
indicated reactions, may be due to inability of the mutant
RapA to eﬃciently remove the transcript from the
polymerase (Figure 5B, bottom panel).
To obtain further evidence for RapA-mediated RNA
remodeling during transcription, we used T4 polynucleo-
tide kinase (T4 PNK) as a gauge for the availability of
the 50-terminus of nascent RNA in in vitro transcription
reactions with or without RapA. We transiently end-
labeled the 50-termini of promoter-speciﬁc transcripts
in medium-duration (15min) in vitro transcription reac-
tions and compared the ratios of the yields of promoter-
speciﬁc transcript in reactions with or without RapA with
those in otherwise identical reactions (sans T4 PNK)
utilizing conventional, uniform RNA labeling (Figure 3C
and D, graphs). The result of this set of experiments
indicated that there was a general (buﬀer- and template-
independent) increase in the eﬃciency of the 50 end-
labeling of nascent RNA in the presence of RapA
X-Ray Film:
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polymerase-RNA
-polymerase
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Figure 4. Immunological characterization of the composition of the RapA-speciﬁc in vitro transcription reaction intermediates. In vitro transcription
reactions similar to those described in Figure 3 (Template 2) were carried out, and the entire reactions were fractionated on 6% polyacrylamide–6M
urea gels (National Diagnostics). Following the electrophoresis, X-ray ﬁlms were exposed to ‘wet’ gels to visualize
32P-labeled RNA transcripts
(left panels). Next, the gel contents were electroeluted onto Hybond P membranes (Amersham Pharmacia Biotech), and the membranes were
immunostained with either RapA- or RNA polymerase-speciﬁc antibodies in independent, parallel reactions (right panels). Western blotting was
performed as described (22). DNA-associated RNA polymerase (indicated with an arrowhead), free RNA polymerase, RNA polymerase–RNA and
RapA–RNA complexes are indicated.
Nucleic Acids Research, 2007, Vol. 35, No. 21 7051(Figure 3C and D, graphs; the sole exception being
Template 4 with Buﬀer ‘B’) indicating RNA remodeling
consistent with either a full transcript release or possibly
partial peeling of the transcript’s 50-terminal segment from
the transcription complex.
Model 2
This model was considered in our earlier study (23), and
it was based on the speculation that RNA polymerase
‘trapped’ on DNA cannot disengage from it in order to
reinitiate new cycles of transcription eﬃciently. If RapA
were indeed to promote transcriptional cycling by displa-
cing RNA polymerase from DNA, under most circum-
stances [the exception being a nearly instantaneous
transfer of the polymerase from the terminator to the
promoter section in the DNA template, which, at least
in theory, cannot be entirely ruled out due to possible
co-alignment of these two sections in supercoiled DNA
(see Ref. 23; Figure 8 therein)] this should be accompanied
by a measurable increase in the fraction of free RNA
polymerase in the system. We tested this possibility using
PAGE- and ultracentrifugation-based techniques. In the
ﬁrst, PAGE-based assay, in vitro transcription reactions
carried out to stationary phase (with or without RapA
present) were fractionated on non-denaturing 5% poly-
acrylamide gels in the presence of magnesium, and the
amounts and subunit composition of the DNA-bound
polymerase were determined (Figure 6). These experi-
ments showed no detectable reduction in the amount of
DNA-associated RNA polymerase in the presence of
RapA (Figure 6, densitogram; compare the levels of the
large RNA polymerase subunits in reactions with or
without RapA). Also, this set of experiments showed that
>85% of RapA dissociated from the DNA-bound RNA
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Figure 5. Kinetics of the RapA–RNA adduct formation and the eﬀect of the RapA Lys183Ala mutation on the RapA–RNA interaction. In vitro
transcription experiments were as described in the Materials and Methods section; denaturation of the samples by boiling following the addition of a
stop solution was omitted. (A) Kinetics of the RapA–RNA adduct formation. In vitro transcription reactions were initiated by the addition of rNTPs
(the ﬁnal concentration of each rNTP was 0.2mM) following a 15-min preincubation of the enzyme(s) with supercoiled DNA at 378C. (B) Eﬀect of
the RapA Lys183Ala mutation [resulting in disruption of the RapA ATPase activity (23)], on the RapA–RNA adduct formation. Bottom panel:
highlight of the results of the experiment.
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70 subunit was
retained by the DNA-bound enzyme (Figure 6, graph).
In the second approach, in vitro transcription reactions
were subjected to ultracentrifugation in order to
determine the fractions of DNA-bound and free RNA
polymerase in reactions with or without RapA. Similarly,
these experiments showed no eﬀect of excess RapA on the
ratio of free and DNA-bound RNA polymerase in
the system (data not shown). Furthermore, a number of
other independent experiments, which assessed the
amount of DNA-associated RNA polymerase in reactions
with or without RapA consistently showed no eﬀect of
RapA on the amount of DNA-associated polymerase
(for example, see Figure 4 above).
Model 3
Nascent RNA may form DNA–RNA complexes poten-
tially inhibitory to transcription, such as DNA–RNA
duplexes and, possibly, non-canonical DNA–RNA com-
plexes, such as DNA–RNA triplexes (28–30). Our recent
study implied that potential non-productive interactions
by nascent RNA may represent a primary obstacle to
continuous transcriptional cycling (26).
Test of the effect of RapA on the stability of DNA–RNA
double-strand complexes. Previously we reported that
RapA showed no detectable DNA helicase activity with
duplex DNA templates (19). During the course of the
next set of experiments, we tested RapAs hypothetical
DNA–RNA helicase activity using a system with immo-
bilized DNA–RNA duplexes. Because the eﬀects of RNA
polymerase and its accessory proteins on the stability
of DNA–RNA double-strand complexes, to the best of
our knowledge, have not been tested before, we used
our previously described technique for puriﬁcation of the
polymerase and its accessory proteins in a single puriﬁca-
tion procedure (25) to isolate multiple proteins in order to
test their eﬀect on the stability of such complexes.
With immobilized duplex RNA–DNA templates, in
which a 55-nt RNA probe consisting of a stem-loop
structure followed by an rA18 tail is hybridized to
Oligo(dT)-agarose, RNA polymerase showed some lim-
ited ability to displace RNA into the soluble phase in the
presence of ATP (Supplementary Data, Figure S5, lane 2),
possibly due to rAn synthesis with Oligo(dT) DNA as a
template. The transcriptional activity of E. coli RNA
polymerase with single-stranded DNA templates has been
reported (31). However, none of the tested proteins,
including RapA, even marginally enhanced or otherwise
altered this activity (Supplementary Data, Figure S5).
Test of the effect of RapA on the stability of DNA–RNA
putative triple-strand complexes. The existence of this type
of interaction has not been deﬁnitively proven in vivo.
However, its in vitro study may arguably yield potentially
new and interesting results. A pioneering work by Roberts
and Crothers presented evidence for the formation of
duplex DNA-single-stranded RNA triplexes in vitro (28).
Because of the overall scarcity of data regarding speciﬁc
conditions for DNA–RNA triplex formation, we ﬁrst set
out to conﬁrm the formation of non-canonical DNA–
RNA complexes in a PAGE-based binding assay that
allows unambiguous detection of complexes between
unmodiﬁed and/or untethered templates. We have
chosen to test the optimal conditions for rA–dA–dT
interaction; the rationale being: (i) the likely similarity of
rA–dA–dT triplexes to dA–dA–dT DNA triplexes, which
are textbook examples of Hoogsteen complexes
proven beyond reasonable doubt, (ii) the study of putative
rA–dA–dT triplexes would be complementary to already
existing data (28) and (iii) homo-dA/dT tracts are
relatively common in both prokaryotes and eukaryotes,
particularly under the promoter and terminator regions.
Under ‘standard’ EMSA conditions (in 0.5  TBE)
model DNA templates (which followed the basic design
introduced in the study referred to above) incorporating
(dA/dT)20 homoduplexes (with varied composition of the
4-nt loop in DNA) showed no interaction with rA20,a s
expected (Figure 7A, Gel 1). However, an increase in the
ionic strength (to 2  TBE) led to the formation of stable
DNA–RNA complexes; the (dA/dT)20 homoduplex was
essential to the interaction (Figure 7A, Gel 2), and the
increase in the length of the dA/dT tract to (dA/dT)40
resulted in an expected gel-retardation eﬀect (Figure 7A,
Gel 2; compare lanes 2 and 3 with lanes 14 and 15).
Interestingly, the composition of the 4-nt loop in DNA
contributed to the strength of the interaction, with C4 or
GATC being more preferred than G4. Stable DNA–RNA
complexes (putative DNA–RNA triplexes) were formed
when 2  TBE was supplemented with 5mM magnesium
chloride (Figure 7A, Gel 3); the reduced mobility of the
nucleic acid probes may be due to Mg
2+–nucleic acid
interaction; however the formation of rA–rA–dT triplexes
under these conditions cannot be entirely ruled out.
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Figure 6. Lack of the RapA eﬀect on the amount of DNA-bound
RNA polymerase in in vitro transcription reactions with supercoiled
DNA. In vitro transcription reactions carried out for 15min at 378Ci n
the presence or absence of RapA were fractionated on non-denaturing
5% polyacrylamide gels, which were cast and run using 2  TBE, and
the amounts of individual RNA polymerase subunits retained on
supercoiled DNA were determined from quantitated SDS gels,
as described in the text. Quantitated levels of RapA and sigma
70
retained by the DNA-bound polymerase are shown in the right panel.
Results of this experiment indicate that RapA does not reduce the
fraction of DNA-bound RNA polymerase during in vitro transcription,
contrary to the previously proposed model (23).
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32P-labeled DNA was used per reaction; data represent the results of four
independent sets of experiments. Coomassie-stained samples of core RNA polymerase (5.6mg) and RapA (1.4mg) used in this experiment are
shown below.
7054 Nucleic Acids Research, 2007, Vol. 35, No. 21The reduced interaction at lowered pH (Figure 7A, Gel 4)
suggests that O
 ...H hydrogen bonds may be essential
for DNA–RNA interaction. Next, we tested RNA probes
in which the RNAs rA18 tract is followed by a stem-loop
structure (thus, the RNAs 30-end is blocked by a ‘non-
interactor’ extension); these templates also formed stable
complexes with the indicated DNA probes under ‘optimal’
conditions—at relatively high salt concentrations, in
the presence of magnesium. A detailed description of
these experiments is provided as Supplementary Data
(Figure S6). In general, our PAGE-based study produced
results consistent with those reported by others (28,29),
with relatively high salt concentrations and magnesium
promoting non-canonical interactions, as reported (29).
Next, we constructed immobilized DNA–RNA com-
plexes, in which 50dA20dC4dT20 DNA was immobilized on
Poly (rA)–agarose, to test the eﬀect of RapA on their
stability. At 200mM NaCl [in 50mM Tris–HCl, pH 7.5,
5mM MgCl2 (Buﬀer C)]—the ‘optimal’ conditions for
the earlier described transcription-stimulatory activity of
RapA (23,26)—the DNA probe (50dA20dC4dT20) formed
a stable complex with Poly(rA)–agarose, as expected.
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Nucleic Acids Research, 2007, Vol. 35, No. 21 7055With these templates, the displacement of DNA from
RNA in reactions containing RNA polymerase and ATP
was enhanced by RapA (Figure 7B, lane 6). When present
at quantities equimolar to that of the polymerase, of all
the transcription factors that were tested, RapA was the
only protein that could assist RNA polymerase in
disrupting DNA–RNA complexes of this type
(Figure 7B). This RapA activity required the presence of
ATP (Figure 7B, lane 6, compare red and blue bars).
Furthermore, increasing the RapA/RNA polymerase
molar ratio to 8:1 resulted in an increase in the amount
of DNA displaced into the ‘soluble’ phase (Figure 7C),
thus supporting the proposition that the ATP-dependent
disruption of DNA–RNA complexes was mediated by
RapA. In the presence of excess RapA, RNA polymerase
and ATP, more than 50% of the total amount of DNA in
the sample was displaced from Poly(rA)–agarose after
30min. Furthermore, both RNA polymerase and RapA
failed to disrupt these dA–dT homoduplex DNA–
Poly(rA)–agarose complexes eﬃciently when tested
:: : : :: :
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Figure 8. Predicted partial structure of the RapA NTPase/(putative) DNA-binding module. RapAs amino acid sequence was threaded into the
SsoRad54–DNA structure via the SWISS-MODEL Protein Modeling Server (32–34). (A) Homology between SWI/SNF subdomain ‘I’ of RapA and
that of the Sulfolobus solfataricus Rad54 homolog (SsoRad54). Identical and homologous amino acids are marked by, respectively, red and blue
boxes. A limited sequence homology between SWI/SNF subdomain ‘I’ of RapA and an RNA-binding, or ‘S1’-module of the ribosomal protein S1 is
also indicated (dashes, colons). The RapA SWI/SNF subdomains are shown schematically at the top; the aligned segments represent the section that
yielded the homology model shown below. (B and C) Predicted structure of the RapA NTPase/(putative) DNA-binding module (sticks and mesh
shown in color) superimposed with the homologous domain of SsoRad54 (gray mesh) bound to DNA (shown as CPK spheres), as reported by the
Hopfner group (24). (D–G) Predicted partial structure of the RapA NTPase module (shown in color) superimposed with the complete SsoRad54
ATPase core–DNA complex (shown in gray scale) (24). Key amino acid changes in the RapA NTPase module relative to that of SsoRad54 are
highlighted as CPK spheres. Lys183 (a highly conserved residue present in both proteins), alanine substitution of which results in signiﬁcantly
reduced ATPase activity in puriﬁed RapA (23), is shown in salmon pink. Several amino acids present in RapA but not found in SsoRad54, such as
Arg222, Arg221, Tyr235 and Glu233, nearly co-align at certain viewpoints along the axis pointing into the DNAs major groove. The ﬁgures were
prepared using PyMOL (DeLano Scientiﬁc LLC, San Carlos, CA).
7056 Nucleic Acids Research, 2007, Vol. 35, No. 21separately (Figure 7C). The ability to separate RNA from
DNA eﬃciently was gained only after mixing the two
puriﬁed enzymes together (Figure 7C), further indicating
the unlikelihood of contaminating enzymatic activities
contributing to the observed eﬀect. Our additional,
control experiments showed that, if treated with
Ribonuclease H (8 U/ml), these dA–dT homoduplex
DNA–Poly(rA)–agarose complexes yielded little or no
DNA in the soluble phase (data not shown), suggesting
non-Watson–Crick base pairing between DNA and
RNA, in accord with our PAGE-based study of similar
DNA–RNA complexes.
DISCUSSION
The nature of the explicit nucleic acid or protein
substrate speciﬁcity of RapA may be the key to under-
standing the primary function of this protein and its
prokaryotic homologs, with possible ramiﬁcations for all
SWI/SNF proteins. Existing studies associate the activity
of SWI/SNF proteins almost exclusively with the remo-
deling of DNA and histone–DNA complexes, and the
recently reported structure of the catalytic domain of the
RapA homolog from S. solfataricus (SsoRad54) com-
plexed to DNA (24) supports the idea of DNA binding by
a bacterial SWI/SNF protein. In order to determine
potential DNA-binding site(s) in RapA, we threaded
RapAs amino acid sequence into the SsoRad54-DNA
structure via the SWISS-MODEL Protein Modeling
Server (32–34). A partial RapA sequence located within
the RapA domain which includes SWI/SNF homology
motifs I–III had a sequence similarity suﬃcient to yield a
homology model of the RapA NTPase/(putative) DNA-
binding module (Figure 8). The RapA and SsoRad54
sequence alignments of this homologous segment—which
loosely overlaps with SWI/SNF subdomain ‘I’ and
Tyr235
Glu233
Lys183
Tyr235
Glu233
Arg221
Arg222
His213 Arg221
D E
Lys183
Lys183
Tyr235 Tyr235
Glu233 Glu233
Arg222
Arg222
Arg221
F G
Figure 8. Continued.
Nucleic Acids Research, 2007, Vol. 35, No. 21 7057includes a highly conserved lysine residue [Lys183, alanine
substitution of which results in a near-knockout of the
RapA ATPase activity (23)] is shown in Figure 8A.
Interestingly, key diﬀerences between this partial RapA
structure and that of SsoRad54 included several charged
amino acids, which nearly co-align at certain viewpoints
(Figure 8F and G) along the axis pointing into the DNAs
major groove. Most prominent of these diﬀerences are
Tyr235 and Glu233, both amino acids facing the DNAs
major groove (Figure 8B, E–G). Other changes, such as
Arg223 and Arg224, as well as His213, would likely fall
into the interface between the two major domains of
RapA [Figure 8E; even though the sequence similarity
between RapA and SsoRad54 within the domain-
harboring SWI/SNF homology modules V–VI was not
suﬃcient to yield a predicted protein structure, it seems
likely that the overall modular organization of the two
proteins must be similar, as there is a consensus regarding
the presence of SWI/SNF homology motifs V and VI in
RapA (1–3) despite the noted dissimilarity of RapA to
the other members of Snf2 family between helicase motifs
III and V (35)].
The homology model of the putative DNA-binding
domain in RapA—taken together with previously
reported results indicating modulation of RapAs tran-
scription-stimulatory activity by supercoiled-to-linear
DNA template transitions (23)—further supports the
idea that RapA indeed possesses an NTPase/DNA-
binding or ‘translocase’ module. And yet, multiple,
independent lines of evidence—accumulated over a
decade through our studies with RapA—point to RNA
as a key nucleic acid substrate of RapA. Below, we
summarize these lines of evidence.
(i) Perhaps the most signiﬁcant result of this study,
the identiﬁcation of stable RapA–RNA transcription
intermediates (which was made possible by the develop-
ment of specialized assays, in which non-denatured in vitro
transcription reactions are fractionated on high-resolution
(43cm–long) 6% polyacrylamide gels containing 6M
urea) clearly points to a transient RapA-transcript
interaction. The RapA–RNA complexes in question are
almost certainly catalytic intermediates; their poorly
deﬁned gel mobilities are likely due to conformational
heterogeneity of the RNA component. Furthermore, our
study of RapAs RNA-binding aﬃnity in a puriﬁed system
also showed signiﬁcantly increased RNA-binding activity
of the polymerase–RapA complex compared to that of the
polymerase alone. RapA showed low RNA-binding
activity in conventional binding assays [Figure 2; also
see (19)] yet formed RNA adducts in ‘functional’ in vitro
transcription reactions. We believe that this apparent
discrepancy may be due to the transient nature of the
(high aﬃnity) RapA–nucleic acid interaction, which,
functionally, may serve the purpose of minimizing
RapA–DNA interaction in the translocating core RNA
polymerase–RapA complex. It is possible to speculate
that a conformational change imposed upon RapA in
termination/post-termination transcription complexes
may trigger the formation of high-aﬃnity RapA–
transcript complexes and their subsequent dissociation
from RNA polymerase; consistent with this, the
experiments described in Figure 6 (conducted under
non-denaturing conditions) point to the dissociation of
RapA from steady-state transcription complexes.
(ii) Our recent, independent study indicated that
potentially non-productive interactions by nascent RNA
may represent a primary obstacle to continuous transcrip-
tional cycling in vitro (26). In that study, we demonstrated
that the transcription-stimulatory activity of RapA, under
certain conditions, can be mimicked by the ribosomal
protein S1 (26), an RNA-binding protein entirely com-
posed of six loosely homologous RNA-binding modules.
The obvious conclusion is that the two proteins may
promote transcriptional cycling by a similar mechanism
which involves protein–nascent RNA interaction (26).
(iii) Studies utilizing two independent techniques
supported the formation of non-canonical DNA–RNA
complexes (putative DNA–RNA triplexes) in vitro. These
DNA–RNA complexes, which may resemble ‘Hoogsteen’
complexes except for their substitution of a single RNA
strand for one of the DNA strands, were stabilized by
relatively high salt concentrations and magnesium, con-
sistent with previous reports (29). It is important to note
that our data show formation of stable non-canonical
DNA–RNA complexes well within the range of intracel-
lular E. coli osmolarity [(36–38), reviewed in Ref. (39)]
suggesting that these potentially non-productive DNA–
RNA interactions may be relevant in vivo. In vitro, RapA
promoted the RNA polymerase-mediated disruption of
DNA–RNA complexes in an ATP-dependent fashion. It is
tempting to speculate that these immobilized templates
could mimic ‘non-productive’ post-termination complexes
referred to earlier (23), however more detailed studies are
needed to consider the possible functional signiﬁcance of
this novel activity of RapA. Coincidentally, a recent study
with eukaryotic SWI/SNF proteins has suggested similar
roles in DNA triplex remodeling (18).
(iv) A number of previously obtained results also
provide correlative data pointing toward the involvement
of RapA in RNA management. (a) Cross-linking of RapA
at the interface of the RNA polymerase alpha and beta-
prime subunits (22) and the competition for binding to
the polymerase between RapA and the RNA-binding
protein S1 (25) (suggesting that RapA may be positioned
near or at the RNA polymerase’s RNA channel), plus
(b) identiﬁcation of RapA as an integral element of the
bacterial apparatus for RNA synthesis (19–23) also
indirectly support its role in RNA management.
Taken together, arguments (i)–(iv) provide a strong
basis for the role of RapA in transcript management.
If RapA indeed possesses a DNA binding or ‘translocase’
module—as further supported by our homology modeling
data—this RNA-binding activity is more likely to be in
addition to its DNA-binding activity. Our work presents
conclusive evidence of RapA-mediated RNA remodeling.
Besides the data supporting a transient RapA–RNA
interaction (which suggests a conformational change in
RNA), two independent, dissimilar sets of experiments
clearly indicate more substantial RapA-mediated RNA
remodeling: (a) RapA made 50-termini of RNA transcripts
more accessible to T4 PNK exchange reaction (at mini-
mum, suggesting possible peeling of the transcripts’
7058 Nucleic Acids Research, 2007, Vol. 35, No. 2150-termini from either DNA or RNA polymerase), and—
in agreement with this—(b) RapA promoted destabili-
zation of non-canonical DNA–RNA complexes (putative
DNA–RNA triplexes) in a system with immobilized
nucleic acid templates. Both results indicate that RapA
may act to free RNA transcript from non-productive
interactions with either DNA or RNA polymerase.
Furthermore, (c) in vitro transcription experiments
(Figure 5B, bottom panel) also suggest such a possibility.
Taken together, our results are consistent with RapA
mediating RNA release from transcription complexes
(Model 1 and variant of Model 3); identiﬁcation of
stable RapA–RNA intermediates in functional in vitro
transcription assays strongly supports this conclusion.
Furthermore, the destabilizing eﬀect of RapA on non-
canonical DNA–RNA complexes (a variant of Model 3)
also supports the RNA release model, if non-canonical
DNA–RNA complexes indeed contribute to the formation
of non-productive PTC. At present, we do not have any
evidence in support of Model 2.
In summary, we propose that RapA remodels RNA–
DNA and/or RNA–RNA polymerase complexes during
transcription; this remodeling may ultimately contribute
to transcript release. Our previously proposed, general
model for RapA catalysis [(23); Figure 8 therein]
thus remains correct; however, we have shifted emphasis
from the possible destabilization of RNA polymerase–
DNA complexes to remodeling of RNA–RNA polymer-
ase and RNA–DNA complexes. We also propose that this
hypothetical role of RapA in RNA remodeling may
include the disruption of salt-stabilized non-canonical
DNA–RNA complexes (putative DNA–RNA triplexes)
(Figure 9); this activity likely accounts for pronounced
slow-growth phenotype of the rapA deletion mutant
(Figure 9, left panels; also, ref. 23), thus explaining the
salt-selectivity of the in vitro and in vivo data.
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